Business of Biotech is a workshop series that introduces grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace. This lecture and workshop series is designed to provide researchers in the life sciences with a comprehensive introduction to the bioscience business environment by exploring the process of transforming a scientific idea into a value-generating product.
Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.
*PLEASE NOTE THAT THESE OCCUR AT VARIOUS LOCATIONS AND CHECK INDIVIDUAL DATES FOR LOCATION INFO*
March 9, 5:30-7:30pm: “Drug Discovery A to Z: Go Ahead And Ask.” Join veteran drug discovery scientists from Charles River for a frank discussion about the drug discovery process.(at Brady Auditorium, 310 Cedar St.)
- 5:30 pm – 6:15 pm: How Do We Prove a Drug Action is Selective?
John Montana, PhD
This talk will describe oversight of the drug discovery process within the pharma & biotech environment and focus on the importance of target engagement biomarkers and the role they can play from a translational efficacy and side effect liability perspective
6:15 pm: All You Need to Know About Drug Development but Were Afraid to Ask (Q&A Round Table)
Questions from the audience will drive a round table featuring a team of experienced drug discovery scientists from Charles River. This interactive session will touch on topics of interest from the audience regarding any aspect of drug discovery, from basic science through the out-licensing of projects and technologies.
April 19, 5:30-7:30pm: “Medical Devices/Diagnostics & Health IT” with Justin Chickles, CEO & Co-Founder, Mobile Sense Technologies, Inc.; Rosemary Harry, President, Device Foundations and Seth Feuerstein, Chief Medical Officer, Magellan Health (at Alexion, 100 College St., New Haven)